510(k) device
Bd Max Ct/Gc/Tv, Bd Max Instrument
Becton, Dickinson and Company · Trichomonas Vaginalis Nucleic Acid Amplification Test System (OUY, Class II) · First FDA decision Sep 6, 2016, newest Sep 6, 2016HIV, hepatitis and sexually transmitted infections
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Bd Max"
MAUDE reports
2,567
Brand "Bd Max", since 2015
PubMed studies
250
Mentioning "Bd Max"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Bd Max Ct/Gc/Tv, Bd Max Instrument
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K151589 · Decided Sep 6, 2016 · 452 days after receipt
Device type: Trichomonas Vaginalis Nucleic Acid Amplification Test System (OUY) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38227First Coast Service Options, Inc.Updated Oct 20, 2023
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38229Novitas Solutions, Inc.Updated Oct 20, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Bd Max", any status and sponsor, newest update first.
- Feasibility of the Maastro Applicator in Rectal CancerActive, not recruiting
Maastricht Radiation OncologyAcademic, hospital or other
NCT06087718 · 10 participants (planned) · Start Aug 27, 2024 · Primary completion Oct 6, 2025
Device: Maastro applicator · For: Rectal Cancer; Feasibility; Toxicity and 5 more
Sites: Maastricht, Netherlands
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Bd Max", and for the whole product code for context.
This brand
2,567 reports: 2,546 malfunction, 18 injury, 3 death
Whole product code OUY
30 reports: 25 malfunction, 5 injury, 0 death
Newest reports for this brand
- BD MAX¿ Enteric Bacterial PanelMalfunction
GENEOHM SCIENCES CANADA, Inc. (BD DIAGNOSTICS)
3007420875-2026-00198 · Received Oct 30, 2026 · Event dated Oct 1, 2026
Device type: Real Time Nucleic Acid Amplification System (OOI)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Kit BD Max CT/GC/TV; Catalog # 442970Terminated
Z-2331-2019 · Started Jul 17, 2019
Reason given: The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly.
Cause as FDA categorized it: Process control · Device type: Trichomonas Vaginalis Nucleic Acid Amplification Test System (OUY)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Bd Max"[tiab]. The summary above synthesizes these.
- BD Max Vaginal Panel for the Detection of Vaginitis.
Barry K, Ceccarelli R · Am Fam Physician · 2023
- BD MAX Enteric Bacterial, Bacterial Plus, and Virus Panels for Diagnosis of Acute Infectious Gastroenteritis: a Cost-Benefit Analysis.
Ferrer J, Giménez E, Carretero D, et al. · Microbiol Spectr · 2022
- Diagnostic performance of DNA probe-based and PCR-based molecular vaginitis testing.
Navarathna DH, Lukey J, Coppin JD, et al. · Microbiol Spectr · 2023Research Support, Non-U.S. Gov't
- Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAXTM System in asymptomatic individuals.
Yanson K, Laviers W, Suhaidi F, et al. · Diagn Microbiol Infect Dis · 2023
- Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays.
Murray P, Cooper C, Maus C · J Clin Microbiol · 2019Letter, Comment
- Comparison of BD MAX Check-Points CPO assay with Cepheid Xpert Carba-R assay for the detection of carbapenemase-producing Enterobacteriaceae directly from rectal swabs.
Yoo IY, Shin DP, Heo W, et al. · Diagn Microbiol Infect Dis · 2022
- Performance of BD MAX Group B Streptococcus (GBS) Assay without Enrichment for the Detection of GBS.
Um S, Her J, Kim SH, et al. · Ann Lab Med · 2022
- Culture and culture-independent diagnostic tests in Campylobacter enteritis.
Özcan N, Bacalan F, Çakr F, et al. · J Infect Dev Ctries · 2022Research Support, Non-U.S. Gov't
- Mapping of etiologies of computed tomography-proven acute colitis: a prospective cohort study.
Meyer J, Schrenzel J, Balaphas A, et al. · Sci Rep · 2022Research Support, Non-U.S. Gov't
- Accuracy of the BD MAXࡊ vaginal panel in the diagnosis of infectious vaginitis.
Aguirre-Quiñonero A, Castillo-Sedano IS, Calvo-Muro F, et al. · Eur J Clin Microbiol Infect Dis · 2019Evaluation Study
- Performances of the BD MAXࡊ CDIFF assay for the detection of toxigenic Clostridioides difficile using Cary-Blair preserved samples.
Anne-Gaëlle R, Célia S, Jeanne C, et al. · Diagn Microbiol Infect Dis · 2022
- Validation of a new extraction-free real-time PCR test to detect MPOX virus.
Lima A, Rowe L, Silbert S · Diagn Microbiol Infect Dis · 2024Validation Study
Other devices of this type
Also filed under product code OUY.
- Xpert TVCepheid · 510(k) 2016
- Aptima Trichomonas Vaginalis Assay - PantherGen-Probe, Inc. · De Novo 2013
- Aptima Trichomonas vaginalis AssayHologic, Inc. · 510(k) 2023
- BD MAX CTGCTV2, BD MAX SystemBecton, Dickinson and Company · 510(k) 2019
- Solana Trichomonas AssayQuidel Corporation · 510(k) 2016
- AmpliVue Trichomonas AssayQuidel Corporation · 510(k) 2015
- Bd Probetec Trichomonas Vaginalis (Tv) Qx Amplified Dna AssayBecton, Dickinson & CO · 510(k) 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.